These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 25743999)
1. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Pogue JM; Kaye KS; Cohen DA; Marchaim D Clin Microbiol Infect; 2015 Apr; 21(4):302-12. PubMed ID: 25743999 [TBL] [Abstract][Full Text] [Related]
2. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy. Ramsamy Y; Muckart DJ; Han KS S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens. Fraimow HS; Tsigrelis C Crit Care Clin; 2011 Jan; 27(1):163-205. PubMed ID: 21144992 [TBL] [Abstract][Full Text] [Related]
4. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do? Penchovsky R; Traykovska M Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Thabit AK; Crandon JL; Nicolau DP Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207 [TBL] [Abstract][Full Text] [Related]
6. New antimicrobial agents for the treatment of bacterial infections in cancer patients. Rolston KV Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance. Lee SY; Kuti JL; Nicolau DP Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance: factors and outcomes. Fish DN; Ohlinger MJ Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001 [TBL] [Abstract][Full Text] [Related]
9. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. McDonald LC Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319 [TBL] [Abstract][Full Text] [Related]
10. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Niederman MS Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320 [TBL] [Abstract][Full Text] [Related]
11. Revisiting "older" antimicrobials in the era of multidrug resistance. Pogue JM; Marchaim D; Kaye D; Kaye KS Pharmacotherapy; 2011 Sep; 31(9):912-21. PubMed ID: 21923592 [TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the ESKAPE pathogens. Pendleton JN; Gorman SP; Gilmore BF Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769 [TBL] [Abstract][Full Text] [Related]
13. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. Hsueh PR; Hoban DJ; Carmeli Y; Chen SY; Desikan S; Alejandria M; Ko WC; Binh TQ J Infect; 2011 Aug; 63(2):114-23. PubMed ID: 21669223 [TBL] [Abstract][Full Text] [Related]